BEAM

Beam Therapeutics
$25.07
−$0.03 (−0.12%)Jul 27, 2026
4.8NeutralMoatMint rating

MoatMint rates Beam Therapeutics (BEAM) 4.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.3 out of 10.

Key metrics

The numbers that frame BEAM today
Market cap
$2.58B
P/E (TTM)
-39.7
EV / FCF
-6.6
Gross margin
100%
EV / Sales
15.5
ROIC
-5.6%
Div yield
0%
Debt / equity
0.2
52wk Low
$15.60
52wk High
$38.26

BEAM stock rating

How BEAM scores on quality, value, growth, momentum and financial health
4.8out of 10
Neutral overallFair business, expensive priceTop 52% of ~5,000 US stocks
QualityFair3.3/10
GrowthFair3.3/10
MomentumGreat8.3/10
ValueFair2.4/10
Financial HealthGood7.9/10

Growth

Revenue and earnings trend for BEAM
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BEAM
Is Beam Therapeutics a good buy?
Hold. Beam Therapeutics has excellent momentum, but weak quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Beam Therapeutics is selling at a very high price.
What is the market capitalization of BEAM?
Beam Therapeutics's market capitalization is $2.58B.
What is the P/E ratio for BEAM stock?
Beam Therapeutics's current P/E ratio is -39.7.
What is the 52-week high for BEAM stock?
The 52-week high for Beam Therapeutics is $38.26. The current close of $25.07 is 34.5% below that high.
What is the 52-week low for BEAM stock?
The 52-week low for Beam Therapeutics is $15.60. The current close of $25.07 is 60.7% above that low.
Does BEAM stock pay dividends?
Beam Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BEAM?
Beam Therapeutics's Debt / Equity ratio is 0.22.